by Eric Christianson | Jul 30, 2025 | Endocrine Medication and Disease State Clinical Pearls
Ertugliflozin was first approved in 2017 for the treatment of type 2 diabetes. This medication is an SGLT2 inhibitor that prevents the resorption of glucose back into systemic circulation. It has been shown to be effective in lowering A1c and managing diabetes. In...
